IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5702-5711

  Colpitts, Sara L ^a   Dalton, Nicole M ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; L SELECTIN; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CYCLE G0 PHASE; CELL DIFFERENTIATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; G0 PHASE; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; L-SELECTIN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 66949134651     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803450     Document Type: Article

References (65)

1. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2: 845-858. (Pubitemid 37328707)
2. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177: 1797-1802.
3. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177: 1505-1509. (Pubitemid 23117143)
4. Nadim, A., E. Javadian, G. Tahvildar-Bidruni, and M. Ghorbani. 1983. Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bull. Soc. Pathol. Exot. Filiales 76: 377-383. (Pubitemid 14229645)
5. Scott, P., D. Artis, J. Uzonna, and C. Zaph. 2004. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol. Rev. 201: 318-338. (Pubitemid 39318461)
6. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110. (Pubitemid 39424872)
7. + T cell population generated during Leishmania major infection requires IL-12 to produce IFN-γ. J. Immunol. 180: 8299-8305.
8. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
9. Li, J., G. Huston, and S. L. Swain. 2003. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J. Exp. Med. 198: 1807-1815. (Pubitemid 38032114)
10. Kondrack, R. M., J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, and L. M. Bradley. 2003. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198: 1797-1806. (Pubitemid 38032113)
11. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033-1041. (Pubitemid 127678737)
12. Wofford, J. A., H. L. Wieman, S. R. Jacobs, Y. Zhao, and J. C. Rathmell. 2008. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 111: 2101-2111.
13. Xue, H. H., P. E. Kovanen, C. A. Pise-Masison, M. Berg, M. F. Radovich, J. N. Brady, and W. J. Leonard. 2002. IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes. Proc. Natl. Acad. Sci. USA 99: 13759-13764.
14. + T cell memory by promoting the generation of IL-7R α-expressing cells. J. Exp. Med. 204: 547-557.
15. Lang, K. S., M. Recher, A. A. Navarini, N. L. Harris, M. Lohning, T. Junt, H. C. Probst, H. Hengartner, and R. M. Zinkernagel. 2005. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 35: 738-745. (Pubitemid 40425529)
16. + T cell responses. J. Immunol. 178: 4027-4031.
17. + T cell response to Listeria monocytogenes infection. J. Immunol. 173: 5679-5687.
18. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
19. + memory T cell subsets. Proc. Natl. Acad. Sci. USA 101: 5610-5615.
20. + T cell subsets identified by expression of IL-7 receptor α and CD62L. J. Immunol. 175: 4686-4696.
21. + effector subpopulations during Toxoplasma gondii infection. J. Immunol. 180: 5935-5945.
22. Harrington, L. E., K. M. Janowski, J. R. Oliver, A. J. Zajac, and C. T. Weaver. 2008. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 452: 356-360. (Pubitemid 351430787)
23. + T cell memory during persistent Trypanosoma cruzi infection. J. Immunol. 181: 2644-2650.
24. McKinstry, K. K., S. Golech, W. H. Lee, G. Huston, N. P. Weng, and S. L. Swain. 2007. Rapid default transition of CD4 T cell effectors to functional memory cells. J. Exp. Med. 204: 2199-2211.
25. Wherry, E. J., D. L. Barber, S. M. Kaech, J. N. Blattman, and R. Ahmed. 2004. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 101: 16004-16009.
26. high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 174: 5926-5930.
27. Wherry, E. J., C. L. Day, R. Draenert, J. D. Miller, P. Kiepiela, T. Woodberry, C. Brander, M. Addo, P. Klenerman, R. Ahmed, and B. D. Walker. 2006. HIV-specific CD8 T cells express low levels of IL-7Rα: implications for HIV-specific T cell memory. Virology 353: 366-373.
28. + T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 36: 336-344.
29. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.
30. Spath, G. F., and S. M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103.
31. Tung, J. W., D. R. Parks, W. A. Moore, L. A. Herzenberg, and L. A. Herzenberg. 2004. New approaches to fluorescence compensation and visualization of FACS data. Clin. Immunol. 110: 277-283.
32. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
33. + T cells. J. Exp. Med. 204: 2015-2021.
34. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
35. Zaph, C., and P. Scott. 2003. Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins. J. Immunol. 171: 4726-4732. (Pubitemid 37310590)
36. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
37. Uzonna, J. E., G. Wei, D. Yurkowski, and P. Bretscher. 2001. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167: 6967-6974.
38. Schluns, K. S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3: 269-279. (Pubitemid 37328680)
39. Hand, T. W., M. Morre, and S. M. Kaech. 2007. Expression of IL-7 receptor α is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc. Natl. Acad. Sci. USA 104: 11730-11735.
40. Haring, J. S., X. Jing, J. Bollenbacher-Reilley, H. H. Xue, W. J. Leonard, and J. T. Harty. 2008. Constitutive expression of IL-7 receptor α does not support increased expansion or prevent contraction of antigen-specific CD4 or CD8 T cells following Listeria monocytogenes infection. J. Immunol. 180: 2855-2862.
41. Nanjappa, S. G., J. H. Walent, M. Morre, and M. Suresh. 2008. Effects of IL-7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice. J. Clin. Invest. 118: 1027-1039.
42. Boyman, O., C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh. 2008. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J. Immunol. 180: 7265-7275.
43. Purton, J. F., C. E. Martin, and C. D. Surh. 2008. Enhancing T cell memory: IL-7 as an adjuvant to boost memory T-cell generation. Immunol. Cell Biol. 86: 385-386.
44. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
45. Shin, H., and E. J. Wherry. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408-415. (Pubitemid 47284857)
46. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
47. + T central memory response in chronic Chagas disease. Nat. Med. 14: 542-550.
48. Martin, D. L., and R. L. Tarleton. 2005. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J. Immunol. 174: 1594-1601.
49. Obar, J. J., S. Fuse, E. K. Leung, S. C. Bellfy, and E. J. Usherwood. 2006. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J. Virol. 80: 8303-8315.
50. + T cell function during viral persistence. J. Immunol. 179: 141-153.
51. Jelley-Gibbs, D. M., J. P. Dibble, S. Filipson, L. Haynes, R. A. Kemp, and S. L. Swain. 2005. Repeated stimulation of CD4 effector T cells can limit their protective function. J. Exp. Med. 201: 1101-1112.
52. Fruth, U., N. Solioz, and J. A. Louis. 1993. Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150: 1857-1864. (Pubitemid 23129662)
53. Chang, J. T., V. R. Palanivel, I. Kinjyo, F. Schambach, A. M. Intlekofer, A. Banerjee, S. A. Longworth, K. E. Vinup, P. Mrass, J. Oliaro, et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315: 1687-1691. (Pubitemid 46515618)
54. Pearce, E. L., and H. Shen. 2007. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 179: 2074-2081.
55. + T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat. Med. 13: 354-360.
56. Haring, J. S., and J. T. Harty. 2006. Aberrant contraction of antigen-specific CD4 T cells after infection in the absence of γ interferon or its receptor. Infect. Immun. 74: 6252-6263.
57. + T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 179: 939-949.
58. low CD8 T cells during infection is regulated by the opposing functions of GABPα and Gfi-1. J. Immunol. 180: 5309-5319.
59. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, and A. Singer. 2004. Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
60. + T cells that had developed an effector phenotype. Science 323: 505-509.
61. + T cells following infection with a gastrointestinal helminth. J. Immunol. 177: 511-518.
62. Titus, R. G., F. J. Gueiros-Filho, L. A. de Freitas, and S. M. Beverley. 1995. Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92: 10267-10271.
63. Schmidt, N. W., R. L. Podyminogin, N. S. Butler, V. P. Badovinac, B. J. Tucker, K. S. Bahjat, P. Lauer, A. Reyes-Sandoval, C. L. Hutchings, A. C. Moore, et al. 2008. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. USA 105: 14017-14022.
64. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
65. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258.